# Mayoo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mayoo

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.mayootech.com
- Latest round: Angel (Jun 28, 2024)
- Investors on record: 3

## About

Based in Shanghai, China, and founded in 2022, Mayoo is a biotechnology company that focuses on the development of enzymatic DNA printing technology. In June 2024, the company closed an angel funding.

The company specializes in enzymatic DNA synthesis which owns protein design technology based on the superimposed physics of big models. The products include the Gibson Assembly gene splicing kit, Golden Gate gene splicing kit, and high-throughput seamless cloning kit. It also offers gene synthesis services. 

The company generates revenue by providing DNA synthesis services and products.

The company will use the angel funds for experimental advancement, instrument development, and team building related to enzymatic DNA synthesis.

## Funding rounds

- Angel, Jun 28, 2024 — Danen Capital, Linear Capital, MiraclePlus

## Investors

- Danen Capital (https://capitalatlas.ai/funds/danen-capital) — Angel
- Linear Capital (https://capitalatlas.ai/funds/linear-capital) — Angel
- MiraclePlus (https://capitalatlas.ai/funds/miracleplus) — Angel